Advances in Biocatalysis and Enzyme Engineering
A special issue of Catalysts (ISSN 2073-4344). This special issue belongs to the section "Biocatalysis".
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 16694
Special Issue Editors
Interests: enzyme engineering; biocatalysis; computational biology; multienzyme cascade reaction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biocatalysis using enzymes or whole cells has become an essential tool in the synthesis of chemicals. As an alternative to traditional chemical processes, biocatalysis is particularly attractive in synthesizing chiral compounds and performing chemically challenging reactions. The discovery and characterization of novel enzymes is important to broaden the applicability of biocatalysis, and engineering of existing enzymes using genetic or chemical modifications not only can deepen our understanding of enzyme structure-function relationship but can also improve biocatalysis with better catalytic performance. In recent years, multienzymatic/cell-free biosynthetic and chemoenzymatic cascade reactions have attracted more attention because they can significantly expand the product scope and synthesize more complex target molecules.
This Special Issue aims to collect original research articles and reviews focused on biocatalysis and enzyme engineering. Submissions from biocatalytic reactions coupled with other types of catalysis such as chemocatalysis or photocatalysis are also welcome.
Dr. Jing Zhao
Dr. Guochao Xu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Catalysts is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript.
The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs).
Submitted papers should be well formatted and use good English. Authors may use MDPI's
English editing service prior to publication or during author revisions.
Keywords
- enzyme
- biocatalysis
- enzyme discovery
- enzyme engineering
- directed evolution
- rational design
- enzyme mechanism
- machine learning
- multienzymatic synthesis/cell-free biosynthesis
- chemoenzymatic synthesis
- artificial cofactor
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.